Cheng‐Chi Chao
Terasaki Foundation(US)RED Consulting (Norway)(NO)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, CAR-T cell therapy research, T-cell and B-cell Immunology, Immune Cell Function and Interaction, vaccines and immunoinformatics approaches
Most-Cited Works
- → IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells(2012)1,030 cited
- → IL-23 Is Critical for Induction of Arthritis, Osteoclast Formation, and Maintenance of Bone Mass(2011)195 cited
- → Islet Allograft Survival After a Single Course of Treatment of Recipient with Antibody to L3T4(1987)175 cited
- → Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis(2010)97 cited
- → CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth(2017)92 cited
- → The role of MHC class II molecules in susceptibility to type I diabetes: Identification of peptide epitopes and characterization of the T cell repertoire(1999)84 cited
- → PSSMHCpan: a novel PSSM-based software for predicting class I peptide-HLA binding affinity(2017)83 cited
- → Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapy(2019)73 cited
- → Selective targeting of the oncogenic KRAS G12S mutant allele by CRISPR/Cas9 induces efficient tumor regression(2020)61 cited
- → Identification of immunogenic epitopes of GAD 65 presented by A g7 in non-obese diabetic mice(1997)60 cited